Trial intelligence / Profile preview

Intraoperative Fluorescent Tracers and Multimodal Imaging in Oral Cancer Surgery

2013-003578-28Phase 2Completed

Sponsor
Andreas Kjær
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of indocyanine green in Oral Mucosal Carcinoma, sponsored by Andreas Kjær. Primary endpoint: Sentinel node detection rate. Started Oct 2013; status: completed.

02

Drugs

indocyanine green
03

Conditions

Oral Mucosal Carcinoma

Beyond the preview

Go deeper on 2013-003578-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003578-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call